INT205265

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.21
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.13
Pain Relevance 0.49

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell proliferation (TSPO) mitochondrion (TSPO) aging (TSPO)
response to stress (TSPO)
TSPO (Homo sapiens)
Pain Link Frequency Relevance Heat
Adalimumab 16 99.90 Very High Very High Very High
anakinra 14 94.08 High High
Infliximab 17 90.16 High High
Etanercept 21 89.32 High High
rheumatoid arthritis 33 68.56 Quite High
methotrexate 2 5.00 Very Low Very Low Very Low
Arthritis 2 5.00 Very Low Very Low Very Low
withdrawal 1 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
spinal inflammation 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Rheumatoid Arthritis 34 68.56 Quite High
Disease 6 5.00 Very Low Very Low Very Low
Necrosis 2 5.00 Very Low Very Low Very Low
Adverse Drug Reaction 2 5.00 Very Low Very Low Very Low
Cancer 2 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
Toxicity 1 5.00 Very Low Very Low Very Low
Fatigue 1 5.00 Very Low Very Low Very Low
Low Back Pain 1 5.00 Very Low Very Low Very Low
Seronegative Spondarthritis 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Up to July 2005, adalimumab had accounted for 6,063 prescriptions (A$11.4 million) under the PBS and 194 prescriptions (A$365,800) under the RPBS.
Regulation (accounted) of Transcription (prescriptions) of PBS associated with adalimumab
1) Confidence 0.21 Published 2007 Journal Aust New Zealand Health Policy Section Body Doc Link PMC1828161 Disease Relevance 0.13 Pain Relevance 0.49

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox